We did not observe differences in the profile or intensity of immunoglobulin deposition (IgG, IgM) or complement proteins (C3, C1q) in our series between patients with and without TMA or individuals that progressed versus patients that did not progress to CKD-KRT. The gene discussed is CD40LG; the disease is chronic kidney disease.